Author response to Colle et al. Issue 6 (23rd June 2021)

• Record Type: Journal Article
• Authors: Fucà, Giovanni; Corti, Francesca; Pietrantonio, Filippo
• Is Part Of: Journal for immunotherapy of cancer. Volume 9:Issue 6(2021)
• Publication Date: 2021-06-23
• Subjects: gastrointestinal neoplasms -- immunotherapy -- tumor biomarkers; Cancer -- Immunotherapy -- Periodicals; Cancer -- Immunological aspects -- Periodicals; Tumors -- Immunological aspects -- Periodicals; Immunotherapy -- Periodicals; 616.99406105
• DOI: 10.1136/jitc-2021-003138
• Languages: English
• ISSNs: 2051-1426

Abstract

Abstract : The event of pseudoprogression is rare in patients with MSI-high metastatic colorectal cancer receiving immune checkpoint inhibitors. In this response to the Letter to the Editor by Colle et al, we highlight that the timing of disease re-assessment may influence the incidence of pseudoprogression, with early assessments being associated with higher incidence. Such dynamics should be considered when interpreting the efficacy of treatment.